David Diamond - Director at Oncotelic Therapeutics, Inc.

Insider Transactions and Holdings

Identity
Entity type
Individual
Role
Director
Issuer context
Issuer symbol
OTLC on OTC
SEC evidence
Source filings
Open source filing history

There are no Buy or Sell transactions made by David Diamond since 31 May 2025

Holdings reported by David Diamond for Oncotelic Therapeutics, Inc.

Form 4 holding Director

Oncotelic Therapeutics, Inc.

Security class
Stock Options
Shares / value
451,467
Estimated value
Report date
08 Jul 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transactions reported by David Diamond for Oncotelic Therapeutics, Inc.

Sym Class Transaction % Reported value Reported price Shares Shares after Date Ownership
* indicates a reported price that failed the local validity check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .